Aller au contenu principal
Profil bibliographique

Maria Aliotti Lippolis

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées
57Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Glioma Diagnosis and TreatmentCerebrospinal fluid and hydrocephalusPituitary Gland Disorders and TreatmentsNeuroblastoma Research and TreatmentsNanoparticle-Based Drug Delivery

Les publications récentes

Accès ouvert 2026 article OpenAlex

Neuro-ophthalmological disturbances in pediatric posterior fossa tumors: Prevalence, risk factors, and outcomes

Maria Aliotti Lippolis, Sabine Koinig, Christian Dorfer, Luca Conci et autres

Abstract Background Neuro-ophthalmological disturbances present frequently in pediatric posterior fossa (PF) tumors, contributing significantly to morbidity. This study evaluates their prevalence, risk factors, and outcomes in affected children. Methods This retrospective study analyzed 119 children with PF tumors treated over a decade …

at (code pays fourni par la source)

0 citations Neuro-Oncology Advances
Accès ouvert 2026 article OpenAlex

Impact of Bevacizumab treatment intervals on surgical interventions in pediatric neuro-oncology

Hannah Schned, Maria Aliotti Lippolis, Cora Hedrich, Natalia Stepien et autres

Abstract Background Bevacizumab (BVZ) is widely used in patients with central nervous system (CNS) tumors. Due to its potential to impair wound healing, a minimum interval of 28 days between BVZ administration and surgery - both before and after the procedure - …

at (code pays fourni par la source)

0 citations Neuro-Oncology Advances
Accès ouvert 2024 article OpenAlex

Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma

Cora Hedrich, Priya Patel, Lukas Haider, Tracey Taylor et autres

Background: Children with craniopharyngiomas (CPs) typically suffer from a life-long chronic disease. The younger the child, the more vulnerable the maturing brain is to invasive therapies such as surgery or radiotherapy. Therefore, treatment modalities facilitating avoidance or delay of invasive therapies are …

at, ca, gb, es (code pays fourni par la source)

8 citations Frontiers in Oncology
Accès ouvert 2024 conference-abstract OpenAlex

ETMR-27. ANTI-ANGIOGENIC METRONOMIC THERAPY OF RARE TUMOURS OF THE CENTRAL NERVOUS SYSTEM

Hannah Schned, Christine Haberler, Andreas Peyrl, Amedeo A. Azizi et autres

Abstract BACKGROUND Improvement of molecular diagnostics has led to significant changes in the categorization of paediatric brain tumours, unveiling novel tumour entities in the latest 2021 WHO classification of central nervous system (CNS) tumours (5th edition), particularly within the group of rare …

at, dk, de, nl, cz, fr (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2024 conference-abstract OpenAlex

PATH-08. PRE-OPERATIVE TUMOUR CLASSIFICATION USING NANOPORE SEQUENCING OF CEREBROSPINAL FLUID

Natalia Stepien, Daniel Senfter, Julia Freund, Sarah Machreich et autres

Abstract BACKGROUND The introduction of tumour classification by analysis of DNA methylation has changed the landscape of paediatric neuro-oncology. With the launch of Oxford Nanopore sequencing, generation of sequencing data is possible in real-time, including information on base-modifications. Diverse classification tools for …

at, de, nl (code pays fourni par la source)

1 citation Neuro-Oncology
Accès ouvert 2024 conference-abstract OpenAlex

CP-07. FEASIBILITY, TOLERABILITY AND FIRST EXPERIENCE OF INTRACYSTIC TREATMENT WITH PEGINTERFERON ALFA-2A IN PATIENTS WITH CYSTIC CRANIOPHARYNGIOMA

Cora Hedrich, Priya Patel, Lukas Haider, Tracey Taylor et autres

Abstract BACKGROUND Craniopharyngiomas (CP) is a life-long chronic disease predominantly affecting young children. Consequently, the developing brain is particularly sensitive to therapies such as surgery or radiotherapy. Hence, therapies allowing to avoid or delay intensive therapies provide substantial benefit. Intracystic injection of …

at, ca, gb, es (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2024 article OpenAlex

The telovelar approach for fourth ventricular tumors in children: is removal of the posterior arch of C1 necessary?

Anna Cho, Maria Aliotti Lippolis, Johannes Herta, Muhammet Doğan et autres

PURPOSE: Various surgical nuances of the telovelar approach have been suggested. The necessity of removing the posterior arch of C1 to accomplish optimal tumor exposure is still debated. Therefore, we report on our experience and technical details of the fourth ventricular tumor …

at (code pays fourni par la source)

2 citations Child s Nervous System
Accès ouvert 2023 article OpenAlex

TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS

Natalia Stepien, Lisa Mayr, Cora Hedrich, Maria Aliotti Lippolis et autres

Abstract Activation of FGF signaling has been described for at least 3% of pediatric solid tumors including pediatric gliomas. Therapeutic actionability of FGF signaling activations, however, remains challenging. Here, we report on three patients with FGFR activation treated with erdafitinib, originally approved …

at, us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2022 conference-abstract OpenAlex

NCMP-10. NEURO-OPHTHALMOLOGICAL FINDINGS IN CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA - A RETROSPECTIVE ANALYSIS

Maria Aliotti Lippolis, Sabine Koinig, Amedeo A. Azizi, Christian Dorfer et autres

Abstract BACKGROUND Medulloblastoma represents the most common malignant pediatric brain tumor. Ophthalmic complications are possible sequelae. METHODS Pediatric medulloblastoma (MB) patients treated at the Medical University of Vienna from January 2012 to August 2021 were analyzed and their last ophthalmic assessment was …

at (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2022 article OpenAlex

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach

Irene Slavc, Lisa Mayr, Natalia Stepien, Johannes Gojo et autres

Medulloblastoma (MB) recurrence is usually incurable despite intensive therapy including high-dose chemotherapy. An evolving alternative approach to conventional chemotherapy aims at interfering with tumor angiogenesis at different levels. We report on a novel combinatorial metronomic antiangiogenic approach. The study is a retrospective …

at, se, dk, fr, de, nl (code pays fourni par la source)

46 citations Cancers
Accès ouvert 2022 article OpenAlex

DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors

Andreas Peyrl, Natalia Stepien, Lisa Mayr, Amedeo A. Azizi et autres

Abstract BACKGROUND: Malignant brain tumors carry a high risk for leptomeningeal dissemination, but the CSF compartment is often not affected by systemic therapy. Intraventricular therapy via an Ommaya reservoir is one possibility to increase the cytotoxic drug concentration in the CSF. Unfortunately, …

at (code pays fourni par la source)

0 citations Neuro-Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.